{"entity":{"type":"insider","cik":"0001378589","url":"/insider/0001378589","json_url":"/insider/0001378589.json","name":"Fenton Mary Kay","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":8,"first":"2011-01-18","last":"2026-02-23","span_basis":"filed_date"},"name_variants":[{"name":"Fenton Mary Kay","source":"filing","n_filings":8,"first_seen":"2011-01-18","last_seen":"2026-02-23"}],"transactions":[{"id":6058445,"accession":"0001193125-26-064261","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-064261","line_url":"/filing/0001193125-26-064261#line-1","is_derivative":false,"issuer_cik":"0001378589","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001378589","owner_cik":"0001378589","owner_name":"Fenton Mary Kay","owner_display_name":"Fenton Mary Kay","owner_url":"/insider/0001378589","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4398.0,"shares_display":"4,398","price_per_share":13.62,"price_display":"13.62","price_state":"stated","total_value":59900.76,"total_display":"59,900.76","total_whole":"59,901","shares_owned_after":126380.0,"shares_owned_after_display":"126,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-20","filed_date":"2026-02-23","scope":"insider"},{"id":2212629,"accession":"0001209191-16-153420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-153420","line_url":"/filing/0001209191-16-153420#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001378589","owner_name":"Fenton Mary Kay","owner_display_name":"Fenton Mary Kay","owner_url":"/insider/0001378589","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":4.11,"price_display":"4.11","price_state":"stated","total_value":10275.0,"total_display":"10,275.00","total_whole":"10,275","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-05","filed_date":"2016-12-05","scope":"insider"},{"id":8929053,"accession":"0001209191-15-087386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-087386","line_url":"/filing/0001209191-15-087386#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001378589","owner_name":"Fenton Mary Kay","owner_display_name":"Fenton Mary Kay","owner_url":"/insider/0001378589","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43500.0,"shares_display":"43,500","price_per_share":10.08,"price_display":"10.08","price_state":"stated","total_value":438480.0,"total_display":"438,480.00","total_whole":"438,480","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-28","filed_date":"2015-12-30","scope":"insider"},{"id":8236139,"accession":"0001181431-15-001443","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-15-001443","line_url":"/filing/0001181431-15-001443#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001378589","owner_name":"Fenton Mary Kay","owner_display_name":"Fenton Mary Kay","owner_url":"/insider/0001378589","role":"Officer (EVP and CFO)","role_mark":"O","role_mark_label":"Officer (EVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13125.0,"shares_display":"13,125","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":210000.0,"total_display":"210,000.00","total_whole":"210,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-23","filed_date":"2015-01-23","scope":"insider"},{"id":3124521,"accession":"0001181431-12-002269","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-12-002269","line_url":"/filing/0001181431-12-002269#line-3","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001378589","owner_name":"Fenton Mary Kay","owner_display_name":"Fenton Mary Kay","owner_url":"/insider/0001378589","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10625.0,"shares_display":"10,625","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":127500.0,"total_display":"127,500.00","total_whole":"127,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-10","filed_date":"2012-01-11","scope":"insider"},{"id":3124517,"accession":"0001181431-12-002269","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-002269","line_url":"/filing/0001181431-12-002269#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001378589","owner_name":"Fenton Mary Kay","owner_display_name":"Fenton Mary Kay","owner_url":"/insider/0001378589","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4375.0,"shares_display":"4,375","price_per_share":9.34,"price_display":"9.34","price_state":"stated","total_value":40862.5,"total_display":"40,862.50","total_whole":"40,863","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-09","filed_date":"2012-01-11","scope":"insider"},{"id":9053618,"accession":"0001181431-11-022767","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-022767","line_url":"/filing/0001181431-11-022767#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001378589","owner_name":"Fenton Mary Kay","owner_display_name":"Fenton Mary Kay","owner_url":"/insider/0001378589","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139.0,"shares_display":"139","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":1042.5,"total_display":"1,042.50","total_whole":"1,043","shares_owned_after":4375.0,"shares_owned_after_display":"4,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-06","filed_date":"2011-04-06","scope":"insider"},{"id":9053617,"accession":"0001181431-11-022767","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-022767","line_url":"/filing/0001181431-11-022767#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001378589","owner_name":"Fenton Mary Kay","owner_display_name":"Fenton Mary Kay","owner_url":"/insider/0001378589","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4111.0,"shares_display":"4,111","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":30832.5,"total_display":"30,832.50","total_whole":"30,833","shares_owned_after":4514.0,"shares_owned_after_display":"4,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-05","filed_date":"2011-04-06","scope":"insider"},{"id":8964231,"accession":"0001181431-11-021289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-021289","line_url":"/filing/0001181431-11-021289#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001378589","owner_name":"Fenton Mary Kay","owner_display_name":"Fenton Mary Kay","owner_url":"/insider/0001378589","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":8625.0,"shares_owned_after_display":"8,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-30","filed_date":"2011-04-01","scope":"insider"},{"id":9023972,"accession":"0001181431-11-004016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-004016","line_url":"/filing/0001181431-11-004016#line-1","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001378589","owner_name":"Fenton Mary Kay","owner_display_name":"Fenton Mary Kay","owner_url":"/insider/0001378589","role":"Officer (SVP and CFO)","role_mark":"O","role_mark_label":"Officer (SVP and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":43750.0,"total_display":"43,750.00","total_whole":"43,750","shares_owned_after":12625.0,"shares_owned_after_display":"12,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-13","filed_date":"2011-01-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001789972","name":"Cullinan Therapeutics, Inc.","url":"/issuer/0001789972","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2026-02-23","last_seen":"2026-02-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001070336","name":"ACHILLION PHARMACEUTICALS INC","url":"/issuer/0001070336","role":"Officer (Chief Financial Officer)","n_filings":7,"first_seen":"2011-01-18","last_seen":"2016-12-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001378589","retrieved_at":"2026-08-23T00:58:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}